Florida Senate - 2010                             CS for SB 2100
       By the Committee on Health Regulation; and Senator Wise
       588-03201-10                                          20102100c1
    1                        A bill to be entitled                      
    2         An act relating to biomedical and social research;
    3         repealing s. 381.0404, F.S., relating to the Center
    4         for Health Technologies; repealing s. 381.85, F.S.,
    5         relating to the Florida Biomedical and Social Research
    6         Act; amending s. 381.855, F.S.; deleting provisions
    7         and cross-references to conform; repealing s. 381.912,
    8         F.S., relating to the Cervical Cancer Elimination Task
    9         Force; repealing ss. 381.92 and 381.921, F.S.,
   10         relating to the Florida Cancer Council and the mission
   11         and duties of the council; amending s. 381.922, F.S.;
   12         providing the goals for the William G. “Bill”
   13         Bankhead, Jr., and David Coley Cancer Research Program
   14         which were transferred from s. 381.921, F.S.; deleting
   15         a cross-reference to conform; providing an effective
   16         date.
   18  Be It Enacted by the Legislature of the State of Florida:
   20         Section 1. Section 381.0404, Florida Statutes, is repealed.
   21         Section 2. Section 381.85, Florida Statutes, is repealed.
   22         Section 3. Paragraph (a) of subsection (5) of section
   23  381.855, Florida Statutes, is amended to read:
   24         381.855 Florida Center for Universal Research to Eradicate
   25  Disease.—
   26         (5) There is established within the center an advisory
   27  council that shall meet at least annually.
   28         (a) The council shall consist of one representative from a
   29  Florida not-for-profit institution engaged in basic and clinical
   30  biomedical research and education which receives more than $10
   31  million in annual grant funding from the National Institutes of
   32  Health, to be appointed by the State Surgeon General from a
   33  different institution each term, and one representative from and
   34  appointed by each of the following entities:
   35         1. Enterprise Florida, Inc.
   36         2. BioFlorida.
   37         3. The Biomedical Research Advisory Council.
   38         4. The Florida Medical Foundation.
   39         5. Pharmaceutical Research and Manufacturers of America.
   40         6. The Florida Cancer Council.
   41         6.7. The American Cancer Society, Florida Division, Inc.
   42         7.8. The American Heart Association.
   43         8.9. The American Lung Association of Florida.
   44         9.10. The American Diabetes Association, South Coastal
   45  Region.
   46         10.11. The Alzheimer’s Association.
   47         11.12. The Epilepsy Foundation.
   48         12.13. The National Parkinson Foundation.
   49         13.14. The Florida Public Health Institute, Inc.
   50         14.15. The Florida Research Consortium.
   51         Section 4. Section 381.912, Florida Statutes, is repealed.
   52         Section 5. Section 381.92, Florida Statutes, is repealed.
   53         Section 6. Section 381.921, Florida Statutes, is repealed.
   54         Section 7. Subsections (2) and (5) of section 381.922,
   55  Florida Statutes, are amended to read:
   56         381.922 William G. “Bill” Bankhead, Jr., and David Coley
   57  Cancer Research Program.—
   58         (2) The program shall provide grants for cancer research to
   59  further the search for cures for cancer.
   60         (a) Emphasis shall be given to the following goals
   61  enumerated in s. 381.921, as those goals support the advancement
   62  of such cures:.
   63         1.Efforts to significantly expand cancer research capacity
   64  in the state by:
   65         a.Identifying ways to attract new research talent and
   66  attendant national grant-producing researchers to cancer
   67  research facilities in this state;
   68         b.Implementing a peer-reviewed, competitive process to
   69  identify and fund the best proposals to expand cancer research
   70  institutes in this state;
   71         c.Funding through available resources for those proposals
   72  that demonstrate the greatest opportunity to attract federal
   73  research grants and private financial support;
   74         d.Encouraging the employment of bioinformatics in order to
   75  create a cancer informatics infrastructure that enhances
   76  information and resource exchange and integration through
   77  researchers working in diverse disciplines, to facilitate the
   78  full spectrum of cancer investigations;
   79         e.Facilitating the technical coordination, business
   80  development, and support of intellectual property as it relates
   81  to the advancement of cancer research; and
   82         f.Aiding in other multidisciplinary research-support
   83  activities as they inure to the advancement of cancer research.
   84         2.Efforts to improve both research and treatment through
   85  greater participation in clinical trials networks by:
   86         a.Identifying ways to increase adult enrollment in cancer
   87  clinical trials;
   88         b.Supporting public and private professional education
   89  programs designed to increase the awareness and knowledge about
   90  cancer clinical trials;
   91         c.Providing tools to cancer patients and community-based
   92  oncologists to aid in the identification of cancer clinical
   93  trials available in the state; and
   94         d.Creating opportunities for the state’s academic cancer
   95  centers to collaborate with community-based oncologists in
   96  cancer clinical trials networks.
   97         3.Efforts to reduce the impact of cancer on disparate
   98  groups by:
   99         a.Identifying those cancers that disproportionately impact
  100  certain demographic groups; and
  101         b.Building collaborations designed to reduce health
  102  disparities as they relate to cancer.
  103         (b) Preference may be given to grant proposals that foster
  104  collaborations among institutions, researchers, and community
  105  practitioners, as such proposals support the advancement of
  106  cures through basic or applied research, including clinical
  107  trials involving cancer patients and related networks.
  108         (5) Funds appropriated for the William G. “Bill” Bankhead,
  109  Jr., and David Coley Cancer Research Program shall be
  110  distributed pursuant to this section to provide grants to
  111  researchers seeking cures for cancer and cancer-related
  112  illnesses, with emphasis given to the goals enumerated in this
  113  section s. 381.921. From the total funds appropriated, an amount
  114  of up to 10 percent may be used for administrative expenses. In
  115  the 2009-2010 fiscal year, 2.5 percent, not to exceed $25
  116  million, of the revenue deposited into the Health Care Trust
  117  Fund pursuant to s. 215.5602(12)(a) shall be transferred to the
  118  Biomedical Research Trust Fund within the Department of Health
  119  for the William G. “Bill” Bankhead, Jr., and David Coley Cancer
  120  Research Program.
  121         Section 8. This act shall take effect July 1, 2010.

Disclaimer: The information on this system is unverified. The journals or printed bills of the respective chambers should be consulted for official purposes. Copyright © 2000-2021 State of Florida.